Trocar Site Hernia After Laparoscopic Cholecystectomy, Supra Versus Infraumbilical Incision for Umbilical Trocar Entry

NCT ID: NCT04254237

Last Updated: 2023-09-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

130 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-02-06

Study Completion Date

2023-03-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Trocar site hernia is a specific complication of laparoscopic surgery. The increasingly frequent use of the laparoscopic approach has resulted in an increase in the number of hernias, mainly at the umbilical area. The appearance of a trocar site hernia can cause complications in the short and long term to the patient who may end up needing a reoperation.

In this study we want to compare the supraumbilical versus the infraumbilical location of the laparoscopy entry trocar, in terms of incisional hernia incidence.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Trocar site hernias have been considered as an underestimated problem by some surgeons. It's incidence varies in the literature between studies, which may be related to an insufficient diagnosis due to poor clinical manifestation and / or the lack of long-term follow-up of patients in some studies.

There are many risk factors that have been related to the trocar site hernia development. On one side, the patient clinical factors as the age, presence of obesity, diabetes mellitus or the smoking habits. On the other side, some risk factors related to the surgical technique have been described, as the entry technique, the size and the locations of the trocars, the fascial closure, the duration of the surgery or the infection of the surgical wound.

Regarding the location of the trocars, it seems that the middle line has more risk of incisional hernia than the lateral areas in the abdomen. However, the trocar locations out of the middle line is not always possible, especially in certain surgeries as the laparoscopic cholecystectomy where it can be necessary an expansion of the incision for removing the specimen. In the concrete case of laparoscopic cholecystectomy, the belly is usually the most popular region for placing the first trocar. However, there is not much evidence about the influence of the most popular locations of the umbilical trocar incision (supra or infraumbilical) in the development of incisional hernias.

In the middle line, the infraumbilical region presents a great ability to adapt to pressure changes, as it physiologically occurs during the pregnancy. On the other side, while the primary hernias in the supraumbilical and umbilical region are common, these are not produced in the infraumbilical region. Besides, in anatomical studies of the linea alba, a higher thickness of the fibres in the infraumbilical region has been observed, along with a different spatial arrangement, predominating the transverse fibres in the infraumbilical region and the oblique ones in the supraumbilical region. Therefore, we hypothesize whether the infraumbilical location of the trocar in the midline, theoretically a more protected region, can reduce the incidence of trocar site hernia in our patients.

The aim of this study is to compare the incidence of the Hasson trocar site hernia between the supra and infraumbilical locations a year after surgery, in high risk patients for trocar site hernia subjected to elective laparoscopic cholecystectomy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Incisional Hernia Cholecystectomy, Laparoscopic

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention group

Infraumbilical Hasson trocar incision.

Group Type ACTIVE_COMPARATOR

Infraumbilical Hasson trocar incision

Intervention Type PROCEDURE

Infraumbilical Hasson trocar incision

Control group

Supraumbilical Hasson trocar incision.

Group Type SHAM_COMPARATOR

Supraumbilical Hasson trocar incision

Intervention Type PROCEDURE

Supraumbilical Hasson trocar incision

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Infraumbilical Hasson trocar incision

Infraumbilical Hasson trocar incision

Intervention Type PROCEDURE

Supraumbilical Hasson trocar incision

Supraumbilical Hasson trocar incision

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Over 18 years old.
* Ability to understand the trial information.
* Patients with symptomatic gallstones or polyps scheduled for laparoscopic cholecystectomy.
* Elective surgery.
* One year potential follow-up.
* Patients that experience one or more of the following Trocar Site Hernia risk factors:

* Over 60 years old.
* Obesity, defined as Body Mass Index (BMI) \> 30 Kg/m2.
* Diabetes mellitus (DM).
* Bronchopathy: A diagnosed Chronic Obstructive Pulmonary Disease (COPD) or smokers of more than 25 cigarette packages/year.
* Accept to participate in the study and sign the informed consent.

Exclusion Criteria

* Contraindication to conduct a laparoscopic cholecystectomy.
* Patients with previous open supramesocolic surgery.
* Patients with previous surgery that affects the umbilical region.
* Patients with umbilical hernia or history of umbilical hernia surgical correction.
* A greater than 30 cm xifo-umbilical distance.
* Extreme obesity (Body Mass Index \> 50 kg/m2).
* Cancer patients or in immunosuppressive therapy.
* Connective tissue disease.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Complejo Hospitalario La Mancha Centro

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Antonio Morandeira Rivas, MD PhD

General Surgeon and Residency program director

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Antonio Morandeira-Rivas, MD PhD

Role: PRINCIPAL_INVESTIGATOR

La Mancha Centro General Hospital

Carlos Moreno Sanz, MD PhD FACS

Role: STUDY_CHAIR

La Mancha Centro General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

La Mancha Centro General Hospital

Alcázar de San Juan, Ciudad Real, Spain

Site Status

Tomelloso General Hospital

Tomelloso, Ciudad Real, Spain

Site Status

Valdepeñas General Hospital

Valdepeñas, Ciudad Real, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

99-B

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.